4-methoxyhonokiol has been researched along with Edema in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, K; Guo, LY; Kang, SS; Kim, YS; Shin, EM; Youn, UJ; Zhou, HY; Zou, LB | 1 |
Ban, JO; Han, SB; Hong, JT; Kang, LL; Kim, KH; Kim, YH; Oh, JH | 1 |
2 other study(ies) available for 4-methoxyhonokiol and Edema
Article | Year |
---|---|
Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
Topics: Acetic Acid; Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Capillary Permeability; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Enzyme Inhibitors; Genes, Reporter; JNK Mitogen-Activated Protein Kinases; Macrophages; Magnetic Resonance Spectroscopy; Magnolia; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitrates; Nitric Oxide Synthase Type II; Nitrites; p38 Mitogen-Activated Protein Kinases; Spectrophotometry, Ultraviolet | 2008 |
Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].
Topics: Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Cell Line, Tumor; Cyclooxygenase 2; Ear Diseases; Edema; Lignans; Lipopolysaccharides; Magnolia; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2009 |